𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Thymosin alpha-1 in malignant gliomas: Augmentation of immune reactivity in a phase I study

✍ Scribed by Arnold M. Baskies; Ayub K. Ortmaya; Paul B. Chreien; John McClure; Allan L. Goldstein

Publisher
Elsevier Science
Year
1981
Tongue
English
Weight
202 KB
Volume
7
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Stereotaxic implantation of 5-fluorourac
Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma : A Phase I study
✍ Philippe Menei; Eric Jadaud; Nathalie Faisant; MichΓ¨le Boisdron-Celle; Sophie Mi πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 200 KB

## Abstract ## BACKGROUND The authors developed a new method of drug delivery into the brain using implantable, biodegradable microspheres. The strategy was evaluated initially to provide localized and sustained delivery of the radiosensitizer 5‐fluorouracil (5‐FU) after patients underwent surgica

A phase I study of recombinant human int
A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma
✍ A. Mittelman; M. Huberman; C. Puccio; B. Fallon; J. Tessitore; S. Savona; R. Eyr πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 662 KB

Preclinical data suggest synergy of interleukin-2 (IL-2) combined with alphainterferon (IFN). In addition, toxicities of IL-2 may be decreased by intermittent continuous infusion. The purpose of this trial was to determine the maximum tolerated dose (MTD) of recombinant IL-2 combined with alpha-IFN